KEGG: ldb:Ldb1710
STRING: 390333.Ldb1710
Ldb1710 is a protein classified as belonging to the UPF0397 protein family, originating from Lactobacillus delbrueckii subsp. bulgaricus. It is a full-length protein consisting of 186 amino acids . Lactobacillus delbrueckii subsp. bulgaricus (often abbreviated as L. bulgaricus) is a gram-positive bacterium commonly used in yogurt production and has significant importance in industrial fermentation processes and as a probiotic organism. The designation "UPF" stands for "Uncharacterized Protein Family," indicating that the precise function of this protein family has not been fully elucidated in the scientific literature.
The UPF0397 protein family represents a group of uncharacterized proteins with conserved sequence motifs across various bacterial species. When investigating Ldb1710, researchers should perform comparative sequence analysis against other UPF0397 family members to identify conserved domains that might suggest functional roles. Methodologically, this involves:
Multiple sequence alignment using tools like Clustal Omega or MUSCLE
Identification of highly conserved residues across family members
Phylogenetic analysis to determine evolutionary relationships between UPF0397 proteins
Structural prediction through homology modeling if crystal structures exist for any family members
These approaches can provide insights into potential functional roles despite the current uncharacterized status of this protein family.
To confirm the molecular characteristics of recombinant Ldb1710, researchers should employ a combination of methods:
The recombinant Ldb1710 protein is available as His-tagged version expressed in E. coli, which facilitates purification and detection using standard protocols . When analyzing the purified protein, researchers should consider potential effects of the His-tag on structure and function, possibly requiring control experiments with tag-cleaved versions.
For optimal expression of recombinant Ldb1710, several systems can be considered:
E. coli expression system is most commonly used and has been successfully employed for Ldb1710 production . When using E. coli, consider:
BL21(DE3) or Rosetta strains to minimize codon bias issues
Temperature optimization (typically 18-30°C for improved solubility)
IPTG concentration titration (0.1-1.0 mM)
Expression in rich media (LB) versus minimal media (depends on downstream applications)
Alternatively, expression in Lactococcus lactis using specialized vectors like pDP359 could provide a more native environment for the protein, potentially improving folding and solubility . This approach leverages the plasmid's ability to replicate in L. lactis while maintaining compatibility with E. coli for molecular manipulations .
Designing an effective shuttle vector for expressing Ldb1710 in Lactobacillus requires consideration of several critical elements:
Origin of replication compatible with both E. coli and Lactobacillus (such as pDP193 component)
A complete plasmid from L. delbrueckii sp. containing all necessary replication elements
Appropriate selection marker, such as chloramphenicol resistance gene engineered with L. bulgaricus promoter elements
Proper transcriptional elements:
The construction procedure should include:
PCR amplification of the promoter region
Restriction digestion and ligation of elements
Verification of construct integrity by restriction analysis
Transformation into E. coli for amplification
A proven example is the pDP359 shuttle vector, which incorporates pDP193 allowing culture in E. coli/Lc. lactis, a complete L. delbrueckii sp. plasmid, and an engineered chloramphenicol resistance gene .
For His-tagged Ldb1710 purification, the following methodological approach is recommended:
| Purification Step | Conditions | Notes |
|---|---|---|
| Cell Lysis | Sonication or French press in buffer containing 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10 mM imidazole | Add protease inhibitors to prevent degradation |
| Clarification | Centrifugation at 15,000 g for 30 min | Remove cell debris and insoluble material |
| IMAC | Ni-NTA or Co-TALON resin, gradient elution with 20-300 mM imidazole | Monitor elution by A280 and SDS-PAGE |
| Polishing | Size exclusion chromatography using Superdex 75/200 | Removes aggregates and impurities |
| Concentration | Ultrafiltration (10 kDa MWCO) | Concentrate to 1-5 mg/ml for storage |
Quality control should include SDS-PAGE, Western blot, and activity assays if available. For long-term storage, add 10% glycerol and store in aliquots at -80°C to maintain protein stability .
Investigating the structural properties of Ldb1710 requires a multi-technique approach:
Primary structure analysis:
Complete sequence verification using mass spectrometry
Identification of conserved motifs via bioinformatic analysis
Secondary structure determination:
Circular Dichroism (CD) spectroscopy to estimate α-helix, β-sheet content
FTIR spectroscopy as complementary technique
Tertiary structure analysis:
X-ray crystallography (requires successful crystallization)
NMR spectroscopy for solution structure (if protein size permits)
Homology modeling based on related structures
Quaternary structure investigation:
Size exclusion chromatography with multi-angle light scattering (SEC-MALS)
Analytical ultracentrifugation to determine oligomerization state
Given that UPF0397 family proteins are uncharacterized, structural analysis may provide the first insights into potential function through identification of structural homology to proteins of known function.
To investigate the biochemical function of the uncharacterized Ldb1710 protein, researchers should employ a systematic approach:
Bioinformatic prediction of function:
Sequence-based function prediction tools
Structural homology modeling with function inference
Genomic context analysis (adjacent genes often have related functions)
Enzymatic activity screening:
General enzymatic assays (hydrolase, oxidoreductase, transferase activities)
Substrate screening panels
Differential scanning fluorimetry with potential ligands/substrates
Protein-protein interaction studies:
Pull-down assays using His-tagged Ldb1710 as bait
Bacterial two-hybrid system
Co-immunoprecipitation with potential partners
In vivo functional analysis:
Gene knockout/knockdown in L. bulgaricus
Phenotypic characterization of mutants
Complementation studies
Since the function of Ldb1710 is currently unknown, a broad initial screening approach followed by focused investigation of promising leads represents the most efficient research strategy.
When encountering expression or solubility issues with recombinant Ldb1710, systematically address potential problems:
| Issue | Troubleshooting Approach | Methodological Details |
|---|---|---|
| Poor expression | Optimize codon usage | Synthesize gene with host-optimized codons or use specialized strains |
| Adjust induction conditions | Test different temperatures (15-37°C), IPTG concentrations (0.1-1 mM), and induction timing | |
| Evaluate different promoters | Compare T7, tac, or native L. bulgaricus promoters | |
| Protein insolubility | Express as fusion protein | Test MBP, SUMO, or thioredoxin fusion tags |
| Modify buffer conditions | Screen buffers with different pH (6.0-8.5), salt (100-500 mM NaCl), and additives (glycerol, detergents) | |
| Use specialized host strains | Try strains co-expressing chaperones or with oxidizing cytoplasm | |
| Protein degradation | Add protease inhibitors | Use complete inhibitor cocktail during lysis and purification |
| Optimize purification speed | Minimize processing time, maintain samples at 4°C | |
| Identify proteolytic sites | Analyze degradation products by mass spectrometry |
For Lactobacillus-specific expression, the pDP359 shuttle vector system that has been specifically designed for L. bulgaricus may resolve many expression issues by providing appropriate replication and expression elements .
When designing experiments to study protein-protein interactions involving Ldb1710, researchers should consider:
Experimental design factors:
Use appropriate controls including:
Negative controls (unrelated proteins with similar properties)
Tagged-only controls (to identify tag-mediated interactions)
Reciprocal confirmation (reverse bait-prey configuration)
Validate interactions through multiple techniques
Consider native vs. denaturing conditions
Technical considerations:
Protein concentration effects on non-specific interactions
Buffer composition impact on interaction stability
Tag position (N- vs. C-terminal) effects on interaction sites
Detection sensitivity and specificity
Bacterial-specific challenges:
Membrane association possibilities
Cell wall interactions
Integration with bacterial metabolic networks
Validation approaches:
In vitro reconstitution of complexes
Functional assays to verify biological relevance
Structural studies of interaction interfaces
Given the uncharacterized nature of UPF0397 family proteins, interaction studies may provide crucial insights into biological function through identification of functional partners or complexes.
Studying Ldb1710 function through gene editing requires specialized approaches for Lactobacillus species:
Knockout strategy development:
CRISPR-Cas9 adaptation for L. bulgaricus:
Design of specific gRNAs targeting ldb1710
Development of Lactobacillus-compatible Cas9 expression
Template design for homology-directed repair
Optimization of transformation efficiency
Phenotypic analysis methodology:
Growth kinetics under various conditions
Metabolic profiling using LC-MS or GC-MS
Stress response evaluation
Competitive fitness assessment
Complementation studies:
The shuttle vector system described in the patent (pDP359) provides a valuable tool for genetic manipulation in L. bulgaricus, enabling both gene deletion and complementation strategies to study Ldb1710 function .
Integrating Ldb1710 into systems biology frameworks requires multi-omics approaches:
Transcriptomic analysis:
RNA-seq to identify co-expressed genes under various conditions
Identification of potential transcriptional networks involving ldb1710
Correlation analysis with metabolic pathways
Proteomic mapping:
Affinity purification-mass spectrometry to identify protein complexes
Phosphoproteomics to detect regulatory modifications
Protein abundance correlation networks
Metabolomic integration:
Identification of metabolites affected by ldb1710 manipulation
Flux balance analysis to predict metabolic impacts
Integration with genome-scale metabolic models
Computational modeling:
Network analysis to position Ldb1710 in cellular pathways
Constraint-based modeling incorporating experimental data
Prediction of emergent properties from multi-omics data integration
These approaches can reveal the functional context of Ldb1710 within L. bulgaricus cellular networks, providing insights even without detailed knowledge of its specific biochemical function.
Understanding Ldb1710 could advance probiotic research through several pathways:
Molecular characterization implications:
Identification of unique functional properties specific to L. bulgaricus
Potential role in adaptation to the gastrointestinal environment
Possible involvement in bacterial-host interactions
Biotechnological applications:
Comparative genomics value:
Identification of strain-specific variations in ldb1710
Correlation of genetic variations with probiotic properties
Taxonomic and evolutionary insights into Lactobacillus species
Practical research methodologies:
Using Ldb1710 as a molecular marker for L. bulgaricus identification
Monitoring gene expression under probiotic-relevant conditions
Strain development through targeted genetic modification
While the specific function of Ldb1710 remains uncharacterized, research into this protein may reveal novel aspects of Lactobacillus biology relevant to its probiotic applications.
When facing contradictory data about Ldb1710 function, researchers should implement rigorous experimental approaches:
Methodological standardization:
Establish consistent protein preparation protocols
Standardize assay conditions and reagents
Document detailed experimental procedures for reproducibility
Multi-laboratory validation:
Independent replication of key experiments
Blind testing protocols to eliminate bias
Statistical meta-analysis of combined datasets
Conditional dependency investigation:
Systematic testing of environmental factors (pH, temperature, ions)
Evaluation of protein modifications or processing requirements
Assessment of co-factor or partner protein dependencies
Alternative hypotheses formulation:
Design critical experiments to distinguish between competing models
Develop null hypothesis significance testing framework
Implement Bayesian analysis for hypothesis comparison
Integration of multiple techniques:
Combine in vitro biochemical assays with in vivo functional studies
Correlate structural information with functional data
Apply complementary methodologies to address the same question
This systematic approach addresses the common challenge of reconciling contradictory findings in uncharacterized protein research.
For optimal Ldb1710 research, consider these expression systems:
The pDP359 shuttle vector is particularly valuable as it contains:
The pDP193 component allowing culture in E. coli/Lc. lactis
A complete L. delbrueckii sp. plasmid with all replication elements
An engineered chloramphenicol resistance gene with a native L. bulgaricus promoter
This vector system enables sophisticated genetic manipulation in L. bulgaricus, which is typically challenging due to transformation barriers and limited genetic tools.
The study of Ldb1710 presents several knowledge gaps and opportunities for future research:
Fundamental characterization needs:
Crystal structure determination
Biochemical function identification
Physiological role in L. bulgaricus
Methodological challenges to address:
Potential research directions:
Comparative analysis across Lactobacillus species
Influence on probiotic properties
Potential biotechnological applications
Integration opportunities:
Positioning within metabolic networks
Role in stress response mechanisms
Contribution to industrial fermentation properties
Researchers should prioritize fundamental characterization while developing improved methodological approaches for genetic manipulation in Lactobacillus species. The plasmid technology described in the patent provides a foundation for these studies but requires further optimization and expansion .